drugset / Trial / NCT07708740

Two Intravenous Doses of Ketamine in Reducing the Oculocardiac Reflex in Adult Patients Undergoing Ophthalmic Surgery

NCT07708740

Recruiting 40 enrolled Cairo University
RandomizedParallel-groupDouble-blindTreatment

Summary

This study aims to evaluate whether a lower dose of ketamine (0.5 mg/kg IV) may be as effective as a higher dose (0.75 mg/kg IV) in reducing oculocardiac reflex (OCR) incidence in adult patients undergoing ophthalmic surgery.

Timeline

Start
2026-07-01
Primary completion
2027-12-30
Completion
2027-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.5 mg/kg Intravenous
Subject Ketamine Small molecule 0.75 mg/kg Intravenous

Indications

No indication recorded.